Immune infiltration-associated serum amyloid A1 predicts favorable prognosis for hepatocellular carcinoma

doi:10.3748/wjg.v26.i35.5287

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 35

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6681)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-7) series, Tables (1-1) series.

Item

Count

PDF

436

WORD

180

HTML

3485

Figures (1-7)

276

Tables (1-1)

194

Sum=4571

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

675

Download

1435

Sum=2110

Sep 21, 2020 (publication date) through Apr 22, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Sep 21, 2020; 26(35): 5287-5301
Published online Sep 21, 2020. doi: 10.3748/wjg.v26.i35.5287

Full Size Figure Download Figure

Figure 5 The association between serum amyloid A1 expression and immune cell abundance in hepatocellular carcinoma. A: A total of 373 hepatocellular carcinoma samples were included to analyze the correlation between SAA1 expression and activated CD8 T cell; B: Natural killer (NK) cell; C: Natural killer T (NKT) cell; D: Th1; E: Th2; F: Th17 cells abundance. SAA1: Serum amyloid A1.

Citation: Zhang W, Kong HF, Gao XD, Dong Z, Lu Y, Huang JG, Li H, Yang YP. Immune infiltration-associated serum amyloid A1 predicts favorable prognosis for hepatocellular carcinoma. World J Gastroenterol 2020; 26(35): 5287-5301
URL: https://www.wjgnet.com/1007-9327/full/v26/i35/5287.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i35.5287